Marker Therapeutics, Inc.

Tagged: targeted tumor lymphocyte summit

Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit

President and CEO, Peter L. Hoang, will be participating at the Tumor Targeted Lymphocyte Summit.

Read More